Skip to content
Cash Flow Statement · TASI 8280

LIVA Insurance Co.
Cash and cash equivalents at period end history.

Cash and cash equivalents at the end of each reporting period. Explore 21 reported observations from 2020 to 2026, with every value linked to its official evidence.

Coverage2020–202621 source-linked periods
Annual history6annual reporting periods
Interim history15quarterly or year-to-date periods
StatementCash Flow Statementas reported by the issuer
Annual series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2025IFRS 17Cash and cash equivalents at period end58.67M SAR

Reporting basis changed · 2023

Cash and cash equivalents at period end025M50M75M100M125M202020212022202320242025
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2026HISTORICALCash and cash equivalents at period end61.25M SAR

Reporting basis changed · 2023

Cash and cash equivalents at period end050M100M150M200M20222023202420252026
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents at period end39.87M SAR

Reporting basis changed · 2023

Cash and cash equivalents at period end020M40M60M20222023202420252026
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents at period end

The series uses the same reporting duration and currency. The filing values appear below.

2026IFRS 17Cash and cash equivalents at period end95.06M SAR

Reporting basis changed · 2023

Cash and cash equivalents at period end050M100M150M200M20222023202420252026
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
9M / Q3 20262026-09-3095055Nine months ended 30 September 202695.06M SARCash and cash equivalents at end of the periodOfficial p. 7 ↗Open statement →
H1 / Q2 20262026-06-3039,867Six months ended 30 June 202639.87M SARCash and cash equivalents at end of periodOfficial p. 8 ↗Open statement →
Q1 20262026-03-3161,245Three months ended 31 March 2026 (Unaudited)61.25M SARCash and cash equivalents at end of the periodNote 4Signed copy p. 8 ↗Saudi Exchange filing ↗Open statement →
FY 20252025-12-3158,6722025-01-01 to 2025-12-3158.67M SARCash and cash equivalents at end of yearOfficial p. 13 ↗Open statement →
9M / Q3 20252025-09-30165,514Nine months ended 30 September 2025 · SAR’000165.51M SARCash and cash equivalents at end of periodNote 4Official p. 8 ↗Open statement →
H1 / Q2 20252025-06-3046,130Six months ended 30 June 2025 · SAR’00046.13M SARCash and cash equivalents at end of periodNote 4Official p. 8 ↗Open statement →
Q1 20252025-03-3148,629Three months ended 31 March 2025 · SAR’00048.63M SARCash and cash equivalents at end of periodNote 4Official p. 8 ↗Open statement →
FY 20242024-12-31Comparative figures in an audited report84,8392024-01-01 to 2024-12-3184.84M SARCash and cash equivalents at end of yearOfficial p. 13 ↗Open statement →
9M / Q3 20242024-09-3089,943Nine months ended 30 September 2024 · SAR’00089.94M SARCash and cash equivalents at end of periodNote 5Official p. 8 ↗Open statement →
H1 / Q2 20242024-06-3037,561Six months ended 30 June 2024 · SAR’00037.56M SARCash and cash equivalents at end of periodNote 5Official p. 8 ↗Open statement →
Q1 20242024-03-31105,224Three months ended 31 March 2024 · SAR’000105.22M SARCash and cash equivalents at end of periodNote 5Official p. 8 ↗Open statement →
FY 20232023-12-31104,4542023-01-01 to 2023-12-31104.45M SARCash and cash equivalents at end of yearNote 6Official p. 11 ↗Open statement →
9M / Q3 20232023-09-3096,152Nine months ended 30 September 202396.15M SARCash and cash equivalents at end of the yearNote 6Official p. 8 ↗Open statement →
H1 / Q2 20232023-06-3050,735Six months ended 30 June 202350.74M SARCash and cash equivalents at end of the yearNote 6Official p. 8 ↗Open statement →
Q1 20232023-03-3158,567Three months ended 31 March 202358.57M SARCash and cash equivalents, end of the yearNote 6Official p. 8 ↗Open statement →
FY 20222022-12-3136,7432022-01-01 to 2022-12-3136.74M SARCash and cash equivalents at end of periodNote 4Official p. 13 ↗Open statement →
9M / Q3 20222022-09-3038454Nine months ended 2022-09-3038.45M SARCash and cash equivalents at end of periodOfficial p. 9 ↗Open statement →
H1 / Q2 20222022-06-3027013Six months ended 2022-06-3027.01M SARCash and cash equivalents at end of periodOfficial p. 9 ↗Open statement →
Q1 20222022-03-31162845Three months ended 2022-03-31162.85M SARCash and cash equivalents at end of periodOfficial p. 9 ↗Open statement →
FY 20212021-12-3140,5922021-01-01 to 2021-12-3140.59M SARCash and cash equivalents at end of periodNote 4Official p. 13 ↗Open statement →
FY 20202020-12-3122,3562020-01-01 to 2020-12-3122.36M SARCash and cash equivalents at end of the yearNote 4Official p. 12 ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

ليفا — Cash and cash equivalents at period end

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.